Joshua Boger, Ph.D. - Publications
Affiliations: | 1989-2009 | CEO | Vertex Pharmaceuticals, Boston, MA, United States |
2012- | Alkeus Pharmaceuticals |
Year | Citation | Score | |||
---|---|---|---|---|---|
1979 | Boger J, Knowles JR. Symmetrical triamino-per-O-methyl-.alpha.-cyclodextrin: a host for phosphate esters exploiting both hydrophobic and electrostatic interactions in aqueous solution Journal of the American Chemical Society. 101: 7631-7633. DOI: 10.1021/Ja00519A036 | 0.522 | |||
1979 | Boger J, Brenner DG, Knowles JR. Symmetrical triamino-per-O-methyl-.alpha.-cyclodextrin: preparation and characterization of primary trisubstituted .alpha.-cyclodextrins Journal of the American Chemical Society. 101: 7630-7631. DOI: 10.1021/Ja00519A035 | 0.486 | |||
1979 | Boger J, Knowles JR. Symmetrical triamino-per-O-methyl-α-cyclodextrin: A host for phosphate esters exploiting both hydrophobic and electrostatic interactions in aqueous solution [13] Journal of the American Chemical Society. 101: 7631-7633. | 0.496 | |||
1978 | Boger J, Corcoran RJ, Lehn J. Cyclodextrin chemistry. Selective modification of all primary hydroxyl groups of ?- and ?-cyclodextrins Helvetica Chimica Acta. 61: 2190-2218. DOI: 10.1002/Hlca.19780610622 | 0.439 | |||
1977 | Boger J, Knowles JR. To stabilize a transition state. Ciba Foundation Symposium. 225-42. PMID 252453 | 0.414 | |||
Show low-probability matches. |